- Home
- Family Medicine
- Phase: IV Cenegermin Trial in Early Neurotrophic Keratopathy
1w3 min read
Medical Article
Introduction Neurotrophic Keratopathy (NK) is a progressive corneal disorder caused by impaired trigeminal innervation, leading to reduced corneal sensitivity and compromised epithelial healing (1). In Stage 1 NK, patients present with superficial punctate keratopathy and early epithelial irregularities that may progress if untreated (1). Cenegermi

Phase: IV Cenegermin Trial in Early Neurotrophic Keratopathy
11 Reached1 Comments
Similar Content

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Catheter Ablation for Atrial Fibrillation with HF
691 Reached

Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

Vildagliptin in Reducing Risk of Post-partum Diabetes
2386 Reached7 Comments4 Likes
